Ubs Oconnor LLC Ptc Therapeutics, Inc. Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 31,435 shares of PTCT stock, worth $1.33 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

31,435

Holding current value

$1.33 Million

% of portfolio

0.08%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $47,560 - $58,937	-1,565 Reduced 4.74%	31,435 $1.17 Million
Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $444,420 - $722,160	18,000 Added 120.0%	33,000 $1.01 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $508,405 - $672,611	-21,052 Reduced 58.39%	15,000 $436,000
Q4 2023 Feb 14, 2024	SELL	$18.07 - $29.37 $118,340 - $192,344	-6,549 Reduced 15.37%	36,052 $993,000
Q3 2023 Nov 14, 2023	SELL	$22.41 - $41.99 $56,025 - $104,975	-2,500 Reduced 5.54%	42,601 $954,000
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $1.82 Million - $2.67 Million	45,101 New	45,101 $1.83 Billion
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $843,641 - $1.08 Million	22,108 Added 67.7%	54,763 $2.65 Million
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $1.09 Million - $1.79 Million	32,655 New	32,655 $0
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $1.67 Million - $2.23 Million	50,000 New	50,000 $1.87 Million

Others Institutions Holding PTCT

# of Institutions

219

Shares Held

78.2M

Call Options Held

111K

Put Options Held

30.6K

Vanguard Group Inc Valley Forge, PA

9.13M
Shares

$387 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

7.89M
Shares

$334 Million
0.05% of portfolio
Black Rock Inc. New York, NY

7.77M
Shares

$329 Million
0.01% of portfolio
Rtw Investments, LP New York, NY

7.39M
Shares

$313 Million
4.37% of portfolio
Armistice Capital, LLC New York, NY

7.23M
Shares

$307 Million
4.46% of portfolio

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account